MLI Stock Overview
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Mesa Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$107.00 |
| 52 Week High | US$125.00 |
| 52 Week Low | US$77.50 |
| Beta | 0.86 |
| 11 Month Change | -6.14% |
| 3 Month Change | -3.60% |
| 1 Year Change | 25.88% |
| 33 Year Change | -60.37% |
| 5 Year Change | n/a |
| Change since IPO | -42.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLI | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -4.5% | 1.7% | -0.2% |
| 1Y | 25.9% | 9.0% | 7.8% |
Return vs Industry: MLI exceeded the German Life Sciences industry which returned 10.6% over the past year.
Return vs Market: MLI exceeded the German Market which returned 9% over the past year.
Price Volatility
| MLI volatility | |
|---|---|
| MLI Average Weekly Movement | 8.0% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MLI's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: MLI's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 736 | Gary Owens | www.mesalabs.com |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries.
Mesa Laboratories, Inc. Fundamentals Summary
| MLI fundamental statistics | |
|---|---|
| Market cap | €578.14m |
| Earnings (TTM) | -€232.63m |
| Revenue (TTM) | €216.28m |
2.6x
P/S Ratio-2.4x
P/E RatioIs MLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLI income statement (TTM) | |
|---|---|
| Revenue | US$228.38m |
| Cost of Revenue | US$83.26m |
| Gross Profit | US$145.12m |
| Other Expenses | US$390.77m |
| Earnings | -US$245.65m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -45.23 |
| Gross Margin | 63.54% |
| Net Profit Margin | -107.56% |
| Debt/Equity Ratio | 127.0% |
How did MLI perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield-1%
Payout RatioDoes MLI pay a reliable dividends?
See MLI dividend history and benchmarks| Mesa Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | Nov 29 2024 |
| Dividend Pay Date | Dec 16 2024 |
| Days until Ex dividend | 15 days |
| Days until Dividend pay date | 32 days |
Does MLI pay a reliable dividends?
See MLI dividend history and benchmarks